KELLI KELLEY: Open Payments
NPI 1376115873 · LENOIR, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 18 payments from 12 companies in 2025. Trend: 2023 $611 · 2024 $376 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 4 | $80 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $60 |
| ABBVIE INC. | 1 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $30 |
| Actelion Pharmaceuticals US, Inc. | 1 | $28 |
| Indivior Inc. | 1 | $26 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| PFIZER INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $18 |
| Corcept Therapeutics | 1 | $14 |
Products named: CAPLYTA, Ozempic, QULIPTA, Kerendia, OPSUMIT, SUBLOCADE, AIRSUPRA, Wegovy.
Industry payments across NC — which companies pay providers there.
